Skip to main content

Designing B-Cell Epitopes for Immunotherapy and Subunit Vaccines

  • Protocol
Peptide Antibodies

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1348))

Abstract

Rationally designed subunit vaccines mainly consist of small peptides or B-cell epitopes, which can stimulate the body’s immune response. Development of subunit vaccines is a very tedious and costly process. One of the imperative and crucial steps of vaccine development is the identification of highly competent B-cell epitopes as most of the proteins and fragments of proteins are immunologically irrelevant. With the advances in bioinformatics tools, it can be possible to precisely narrow down potential B-cell epitopes from the whole proteome of any pathogen. This chapter sheds light on prediction and designing of B-cell epitopes using two in silico tools LBtope and IgPred.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Black M, Trent A, Tirrell M, Olive C (2010) Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists. Expert Rev Vaccines 9:157–173

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Purcell AW, McCluskey J, Rossjohn J (2007) More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov 6:404–414

    Article  CAS  PubMed  Google Scholar 

  3. BenMohamed L, Wechsler SL, Nesburn AB (2002) Lipopeptide vaccines – yesterday, today, and tomorrow. Lancet Infect Dis 2:425–431

    Article  CAS  PubMed  Google Scholar 

  4. Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M (2010) Synthetic therapeutic peptides: science and market. Drug Discov Today 15:40–56

    Article  CAS  PubMed  Google Scholar 

  5. Kaspar AA, Reichert JM (2013) Future directions for peptide therapeutics development. Drug Discov Today 18:807–817

    Article  CAS  PubMed  Google Scholar 

  6. Weinstock GM, Peacock SJ (2014) Nextgeneration pathogen genomics. Genome Biol 15:528

    Google Scholar 

  7. Dhanda SK, Gupta S, Vir P, Raghava GP (2013) Prediction of IL4 inducing peptides. Clin Dev Immunol 2013:263952

    Article  PubMed Central  PubMed  Google Scholar 

  8. Dhanda SK, Vir P, Raghava GP (2013) Designing of interferon-gamma inducing MHC class-II binders. Biol Direct 8:30

    Article  PubMed Central  PubMed  Google Scholar 

  9. Singh H, Ansari HR, Raghava GP (2013) Improved method for linear B-cell epitope prediction using antigen’s primary sequence. PLoS One 8, e62216

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Gupta S, Ansari HR, Gautam A, Raghava GP (2013) Identification of B-cell epitopes in an antigen for inducing specific class of antibodies. Biol Direct 8:27

    Article  PubMed Central  PubMed  Google Scholar 

  11. Ansari HR, Raghava GP (2010) Identification of conformational B-cell Epitopes in an antigen from its primary sequence. Immunome Res 6:6

    Article  PubMed Central  PubMed  Google Scholar 

  12. Hu YJ, Lin SC, Lin YL, Lin KH, You SN (2014) A meta-learning approach for B-cell conformational epitope prediction. BMC Bioinformatics 15:378

    Article  PubMed Central  PubMed  Google Scholar 

  13. Krawczyk K, Liu X, Baker T, Shi J, Deane CM (2014) Improving B-cell epitope prediction and its application to global antibody-antigen docking. Bioinformatics 30:2288–2294

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Roos A, Bouwman LH, van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL et al (2001) Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 167:2861–2868

    Article  CAS  PubMed  Google Scholar 

  15. Webster SD, Galvan MD, Ferran E, Garzon-Rodriguez W, Glabe CG et al (2001) Antibody-mediated phagocytosis of the amyloid beta-peptide in microglia is differentially modulated by C1q. J Immunol 166:7496–7503

    Article  CAS  PubMed  Google Scholar 

  16. Mitchell TJ, Andrew PW, Saunders FK, Smith AN, Boulnois GJ (1991) Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol Microbiol 5:1883–1888

    Article  CAS  PubMed  Google Scholar 

  17. Galli SJ, Tsai M (2012) IgE and mast cells in allergic disease. Nat Med 18:693–704

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Jain S, Rosenthal KL (2011) The gp41 epitope, QARVLAVERY, is highly conserved and a potent inducer of IgA that neutralizes HIV-1 and inhibits viral transcytosis. Mucosal Immunol 4:539–553

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gajendra P. S. Raghava .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this protocol

Cite this protocol

Singh, H., Gupta, S., Gautam, A., Raghava, G.P.S. (2015). Designing B-Cell Epitopes for Immunotherapy and Subunit Vaccines. In: Houen, G. (eds) Peptide Antibodies. Methods in Molecular Biology, vol 1348. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2999-3_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2999-3_28

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-2998-6

  • Online ISBN: 978-1-4939-2999-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics